HANNAH JONES: Open Payments
NPI 1689191827 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 24 payments from 10 companies in 2025. Trend: 2023 $178 · 2024 $644 · 2025 $610
Food & beverage: $425Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $140 |
| ABBVIE INC. | 6 | $130 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| UCB, Inc. | 4 | $77 |
| GENZYME CORPORATION | 4 | $72 |
| Galderma Laboratories, L.P. | 1 | $36 |
| KYOWA KIRIN, INC. | 1 | $19 |
| Organon LLC | 1 | $19 |
| LEO Pharma Inc. | 1 | $18 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $14 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Bimzelx, NEMLUVIO, RINVOQ, POTELIGEO, VTAMA.
Industry payments across ID — which companies pay providers there.
